- Senate Bill 785 changes the definition of “employer” under Maryland’s Parental Leave Act to exclude those already covered by FMLA, even if they
Maryland FAMLI Program Delayed
Employers with employees in Maryland need to be aware of delays in the implementation of Maryland’s new Family and Medical Leave Insurance (FAMLI) program. The new timeline is discussed in our article New Dates Announced for Maryland’s Delayed FAMLI Program. We are monitoring these developments closely.
Maryland DOL Proposes Delaying FAMLI Program
The Maryland Department of Labor is proposing delaying implementation of the Family and Medical Leave Insurance (FAMLI) program. Under the new recommended plan, payroll deductions would begin January 1, 2027 and benefits would become available on January 1, 2028. This proposed change will need to be approved by the General Assembly. In light of the
EEOC Issues New Guidance on Wearable Technologies: Key Points for Employers
As more employers incorporate wearable technology in the workplace, including those enhanced by artificial intelligence, the Equal Employment Opportunity Commission (EEOC)’s new fact sheet “Wearables in the Workplace: The Use of Wearables and Other Monitoring Technology Under Federal Employment Discrimination Laws,” offers important considerations for employers. The EEOC explains how employers can navigate
Maryland’s Paid Family and Medical Leave Insurance Program Coming Soon
The Maryland Department of Labor recently published proposed regulations to implement the state’s paid family and medical leave insurance program. Although they are not final yet, the proposed regulations provide important information for employers as they prepare for the new mandatory program. Payroll deductions will start July 1, 2025, and benefits will be available beginning
Five Takeaways for Employers Implementing FMLA Leave for Clinical Trials
The DOL Wage and Hour Division’s recently issued opinion letter clarifies the scope of permitted uses of Family Medical Leave Act leave. Specifically, it affirms that eligible employees may use FMLA leave for medical interventions provided as part of clinical trials, regardless of whether the treatment is experimental or involves placebos. Highlights from the DOL’s